Renal Tubular Acidosis

Robert Todd Alexander1, Martin Bitzan2

  • 1Department of Pediatrics and Physiology, Stollery Children's Hospital, 11405-87 Avenue, Edmonton, Alberta T6G 1C9, Canada.

Insights

Renal tubular acidosis (RTA) in children presents as metabolic acidosis. Diagnosis and type determination are crucial for prognosis and treatment, with stone risk varying by RTA type.

Area of Science:

  • Pediatric Nephrology
  • Acid-Base and Electrolyte Disorders
  • Metabolic Diseases

Background:

  • Renal tubular acidosis (RTA) is a critical condition in pediatric patients.
  • Early suspicion in poorly thriving children with specific metabolic acidosis is key.
  • Understanding RTA subtypes is essential for effective management.

Purpose of the Study:

  • To highlight the diagnostic criteria for RTA in young children.
  • To emphasize the importance of differentiating RTA types for treatment and prognosis.
  • To discuss the implications of RTA subtypes on nephrolithiasis and calcinosis risk.

Main Methods:

  • Clinical presentation analysis of pediatric RTA cases.
  • Biochemical workup including anion gap, potassium levels, and urine citrate excretion.
  • Correlation of RTA type with syndromic features, stone risk, and treatment strategies.

Main Results:

  • Hyperchloremic, hypokalemic normal anion gap metabolic acidosis suggests RTA in infants.
  • Urine citrate levels differentiate proximal RTA (negligible stone risk) from distal RTA (high stone risk).
  • Further workup is necessary to determine specific RTA type and etiology.

Conclusions:

  • Prompt diagnosis of RTA in children is vital for appropriate management.
  • Identifying RTA type guides treatment choices and predicts prognosis, particularly regarding stone formation.
  • Novel slow-release alkali and potassium supplements show promise for simplified and sustained RTA correction.

Related Concept Videos

Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
850
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
882
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.4K
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
5.0K
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.2K
Vesicular Tubular Clusters01:45

Vesicular Tubular Clusters

After budding out from the ER membrane, some COPII vesicles lose their coat and fuse with one another to form larger vesicles and interconnected tubules called vesicular tubular clusters or VTCs. These clusters constitute a compartment at the ER-Golgi interface known as ERGIC (Endoplasmic Reticulum Golgi Intermediate Compartment). The ERGIC is a mobile membrane-bound cargo transport system that sorts proteins secreted from ER and delivers them to the Golgi.
With the help of motor proteins such...
3.2K